Easton Pharmaceuticals Inc., a specialty pharmaceutical company, designs, develops, and markets various topically delivered drugs and therapeutic health care products. Its products include Nauseasol, a motion sickness gel; Skin Renou HA, an anti-aging wrinkle cream using hyaluronic acid, which keeps the skin smooth; Kenestrin Gel used for arthritis, knees, elbows, shoulders, wrist, and back pain; Viorra, a hormone free, non-toxic, and topical gel that improves sexual functioning of women; and female sexual arousal disorder drug. The company is also developing XILIVE, an early stage cancer drug. In addition, it is involved in the medical marijuana business. The company was formerly known as LAM Industries, Inc. and changed its name to Easton Pharmaceuticals Inc. in March 2010. Easton Pharmaceuticals Inc. was founded in 1997 and is based in Toronto, Canada.
Industry, Sector and Symbol
Industry Drug Manufacturers - Specialty & Generic
Sub-IndustryN/A
SectorMedical
CIKN/A
Phone416-619-0291
Debt
Price-To-Earnings
Sales & Book Value
Annual SalesN/A
Profitability
Miscellaneous
EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable
Easton Pharmaceuticals (OTCMKTS:EAPH) Frequently Asked Questions
What is Easton Pharmaceuticals' stock symbol?
Easton Pharmaceuticals trades on the OTCMKTS under the ticker symbol "EAPH."
Has Easton Pharmaceuticals been receiving favorable news coverage?
Headlines about EAPH stock have trended somewhat negative this week, InfoTrie reports. The research group identifies positive and negative press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Easton Pharmaceuticals earned a media sentiment score of -1.5 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the company's share price in the next several days. View News Stories for Easton Pharmaceuticals.
Who are some of Easton Pharmaceuticals' key competitors?
Some companies that are related to Easton Pharmaceuticals include 1933 Industries (TGIF), Abacus Health Products (ABAHF), Acreage (ACRGF), Alliance Growers (ACG), Applied Biosciences (APPB), Biome Grow (BIO), Blueberries Medical (BBM), Cannabis Science (CBIS), Cannara Biotech (LOVE), Cansortium (CNTMF), Charlotte's Web (CWBHF), Choom (CHOOF), Cipher Pharmaceuticals (CPHRF), CLS Holdings USA (CLSH) and Cosmos (COSM).
What other stocks do shareholders of Easton Pharmaceuticals own?
Who are Easton Pharmaceuticals' key executives?
Easton Pharmaceuticals' management team includes the folowing people:
- Mr. Evan Karras, CEO, Pres, Sec. & Director
- Mr. Nunzio J. Valerie Jr., CFO & Director (Age 57)
- Mr. Vince Demasi, COO & Director
- Dr. Lilla Albert Ph.D., Chief Marketing and Technology Officer
- Ms. Elena Milantoni, Director of Fin. and Admin. (Age 49)
How do I buy shares of Easton Pharmaceuticals?
Shares of EAPH can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is Easton Pharmaceuticals' stock price today?
One share of EAPH stock can currently be purchased for approximately $0.0045.
What is Easton Pharmaceuticals' official website?
How can I contact Easton Pharmaceuticals?
The company can be reached via phone at 416-619-0291.
MarketBeat Community Rating for Easton Pharmaceuticals (OTCMKTS EAPH)
MarketBeat's community ratings are surveys of what our community members think about Easton Pharmaceuticals and other stocks. Vote "Outperform" if you believe EAPH will outperform the S&P 500 over the long term. Vote "Underperform" if you believe EAPH will underperform the S&P 500 over the long term. You may vote once every thirty days.
